ArticleCurrent HIV research2022
TLR3 Polymorphisms in HIV-infected Individuals Naïve to ART.
Article in Current HIV research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 3 citations in OpenAlex.
- Machine Learning Application in Enhancing HIV Management and Treatment Outcomes: Revolutionizing HIV Infection.Current HIV research · 2026Review
- Article
- Polymorphisms in the genes encoding RLR and TLR3 and CMV DNAemia in subjects coinfected with human immunodeficiency virus and cytomegalovirus.Archives of virology · 2024Article
- Analysis of associations between theFrontiers in cellular and infection microbiology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTLR3 polymorphisms affect the risk of HIV infection and modify the disease course. Consequently, we analyzed the association of TLR3 polymorphism (rs5743312, rs3775296, and rs3775291) with susceptibility to HIV-1 acquisition and disease progression.
methodsThis is a cross-sectional study. Genotyping of TLR3 polymorphisms is completed by utilizing the PCR-RFLP technique in 153 HIV naive subjects and 158 healthy controls.
resultsA haplotype is a physical grouping of genomic variants that tend to be inherited together. The TCC haplotype was increased in HIV-infected individuals compared with healthy controls (0.05% versus 0.03%). TLR3 rs3775291CT genotype was associated with the early stage of HIV infection (OR = 2.19, P = 0.04), with a higher occurrence in the advanced stage of HIV infection when contrasted with healthy controls (41.2% versus 32.3%). TLR3 rs3775296 CA genotype was likely to be associated with the intermediate stage of HIV infection (19.5% versus 31.6%, OR = 0.42, P = 0.06). TLR3 rs5743312TT genotype was more prevalent in the advanced stage of HIV infection compared with healthy controls (2.9% versus 1.9%). TLR3 rs3775296CA genotype was less prevalent in HIV subjects devouring tobacco when contrasted with non-users (9.1% versus 34.9%, OR = 0.25, P = 0.09). TLR3 rs3775296AA and rs3775291CT and TT genotypes have been overrepresented in HIV subjects using alcohol when contrasted with non-users (5.6% versus 1.1%, OR = 1.83, P = 0.67; 50.0% versus 42.2%, OR = 1.84, P = 0.31; 5.6% versus 3.3%, OR = 2.70, P = 0.50). In the multivariate examination, the rs5743312TT genotype showed a greater risk for HIV infection (OR = 1.86, P = 0.50).
conclusionTLR3 rs3775291 C/T polymorphism may assist the risk of disease progression in alcohol consumers. TLR3 rs3775291 CT genotype may enhance the disease progression, whereas the TLR3 rs3775296 CA genotype may protect against disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.